Homburger is adept at handling a broad array of matters within the healthcare and life sciences sector. The team has particular strengths in patent-related litigation, M&A, capital markets and licensing transactions, as well as financial restructurings of companies within the industry. Practice head Andri Hess leads the patent litigation side of the practice and also undertakes licensing contracts negotiations and other regulatory matters. Co-heads Daniel Häusermann and Richard Stäuber are also recommended. Häusermann advises on M&A, ECM and other financing transactions, while regulatory specialist Stäuber has extensive knowledge of both Siss and European competition law.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Andri Hess is exceptional. He is extremely knowledgeable on patent law and case law and is a very experienced IP litigator in the healthcare space.'
- 'Andri Hess is an excellent strategic thinker and can distil out important points rapidly. He will understand any case to the very bottom.'
Key clients
- Novo Nordisk
- BeOne
- Roche
- Sandoz
- Novartis
- ADC Therapeutics
- Catalent
- Addex Therapeutics
- BioVersys
- Molecular Partners
- Taiho Pharmaceutical
- Biocorp Holding
Work highlights
Represented Sandoz in a patent invalidity action against Bayer before the Swiss Federal Supreme Court.
Advised Novo Nordisk on the $11bn acquisition of three manufacturing sites following its Catalent deal.
Advised BioVersys on its IPO on the SIX Swiss Exchange.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Andri Hess; Richard Stäuber; Daniel Häusermann